The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Review article: the burden of hepatic encephalopathy
Abstract
Hepatic encephalopathy, a challenging complication of advanced liver disease, occurs in approximately 30–45% of patients with cirrhosis and 10–50% of patients with transjugular intrahepatic portosystemic shunt, while minimal hepatic encephalopathy affects approximately 20–60% of patients with liver disease. Although the total direct and indirect costs of hepatic encephalopathy have not been formally quantified, data from the Healthcare Cost and Utilization Project suggest that hepatic encephalopathy‐related hospitalizations are associated with substantial costs. In 2003, there were over 40 000 patients hospitalized in the United States for a primary diagnosis of hepatic encephalopathy, resulting in total charges of approximately $932 million. Furthermore, trends over the past 10 years suggest that the burden of hepatic encephalopathy is increasing, as indicated by increases in hospital admissions and higher charges per stay. Because of inconsistencies in coding for hepatic encephalopathy, the prevalence and cost data from this data source are believed to significantly underestimate the true burden of hepatic encephalopathy. In addition, expenditures for physician fees and out‐patient care, as well as indirect costs attributable to lost work days and decreased productivity, have not been quantified. Thus, there is need for future studies to more accurately define the burden of hepatic encephalopathy, including minimal hepatic encephalopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
Bustamante, J., Rimola, A., Ventura, P.-J., Navasa, M., Cirera, I., Reggiardo, V., & Rodés, J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80144-5 · Cited by 567
Subclinical hepatic encephalopathy impairs daily functioning
Groeneweg, M., Quero, J. C., De Bruijn, I., Hartmann, I. J. C., Essink-bot, M.-L., Hop, W. C. J., & Schalm, S. W. (1998) · Hepatology · doi:10.1002/hep.510280108 · Cited by 506
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension†
Boyer, T. D., & Haskal, Z. J. (2005) · Hepatology · doi:10.1002/hep.20559 · Cited by 445
Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy
Romero-Gómez, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02692-2 · Cited by 411
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A., & Häussinger, D. (2002) · Hepatology · doi:10.1053/jhep.2002.30957 · Cited by 397
Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis
Das, A., Dhiman, R. K., Saraswat, V. A., Verma, M., & Naik, S. R. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02487.x · Cited by 298
Minimal hepatic encephalopathy impairs fitness to drive
Wein, C., Koch, H., Popp, B., Oehler, G., & Schauder, P. (2004) · Hepatology · doi:10.1002/hep.20095 · Cited by 291
Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations
Ortiz, M., Jacas, C., & Córdoba, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.028 · Cited by 274
Amodio, P., Del Piccolo, F., Pettenò, E., Mapelli, D., Angeli, P., Iemmolo, R., Muraca, M., Musto, C., Gerunda, G., Rizzo, C., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00129-5 · Cited by 262
The prognostic significance of subclinical hepatic encephalopathy
Hartmann, I. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01057-1 · Cited by 244
Cited by
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Self-citationSharma, B. C., Sharma, P., Lunia, M. K., Srivastava, S., Goyal, R., & Sarin, S. K. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.219 · Cited by 343
Metadata
- Authors
- POORDAD, F. F.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-01-23
- Volume
- 25
- Issue
- s1
- Pages
- 3-9
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1665985473
- Cited by
- 400
- References
- 15
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: the burden of hepatic encephalopathy. https://app.cochat.ai/papers/10.1111/j.1746-6342.2006.03215.x
- The paper
- POORDAD, F. F. (2007). Review article: the burden of hepatic encephalopathy. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1746-6342.2006.03215.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.